News & Resources

THG Digital 9/22/25 THG Digital 9/22/25

Rethinking What We Know About U.S. Drug Prices

Read More

THG Digital 9/22/25 THG Digital 9/22/25

Trump’s art of the deal play on healthcare could slash medical costs

Read More

THG Digital 9/19/25 THG Digital 9/19/25

US Weighs Trump-Branded Website to Help Shop for Cheaper Drugs

Read More

THG Digital 9/16/25 THG Digital 9/16/25

Europe is not pulling its weight in paying for drug development, says Tomas Philipson

Read More

THG Digital 9/11/25 THG Digital 9/11/25

White paper: U.S. Drug Prices Set to Fall Without Government Price Controls

Read More

THG Digital 9/10/25 THG Digital 9/10/25

Congress accelerating the decline of medical innovation

Read More

THG Digital 9/10/25 THG Digital 9/10/25

Trump's Tariff Strategy Can Even the Playing Field on Drug Prices

Read More

THG Digital 9/8/25 THG Digital 9/8/25

From Patients To Consumers: Direct-To-Consumer Pricing As A Model For Healthcare Reform

Read More

THG Digital 8/18/25 THG Digital 8/18/25

Trump Is Making Healthcare A Winning “80/20” Political Issue For GOP

Read More

THG Digital 8/14/25 THG Digital 8/14/25

Op-Ed: Terry Wilcox: Why Most Favored Nation pricing risks putting America last

Read More

THG Digital 8/13/25 THG Digital 8/13/25

TAPP Applauds New “Most Favored Patient” Healthcare Initiative

Read More

THG Digital 8/13/25 THG Digital 8/13/25

New “Most Favored Patient” Reform Initiative: A Bold Policy Blueprint for Lower Costs, Greater Access and Better Healthcare

Read More

THG Digital 8/11/25 THG Digital 8/11/25

Trump can rein in healthcare costs AND win medical breakthroughs — here’s how

Read More

THG Digital 8/8/25 THG Digital 8/8/25

Drugmakers Are Embracing Direct-To-Consumer Sales. That's Fantastic News For Patients.

Read More

THG Digital 8/7/25 THG Digital 8/7/25

Letter to Congress Announcing Most Favored Patient Initiative

Read More